Back to search
FDAFDA · Food and drugs·Recall number D-1848-2019

Gatifloxacin Ophthalmic Solution 0.5%, 2.5 mL per bottle, Rx Only, Mfd. for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505. Made in India. NDC: 0378-5431-35

Published September 18, 2019 · Recall initiated: September 6, 2019

Summary

FDA records drug Class III recall D-1848-2019, published September 18, 2019 and initiated September 6, 2019. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 13,157 5 mL bottles; Lot: Lot GABH0003, EXP 7/2020. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications:OOS for unknown impurity.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mylan Pharmaceuticals Inc.
Distributor
Nationwide in the USA
Lot
Lot GABH0003, EXP 7/2020
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Gatifloxacin Ophthalmic Solution 0.5%, 2.5 mL per bottle, Rx Only, Mfd. for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505. Made in India. NDC: 0378-5431-35 recalled?

Yes. FDA published recall D-1848-2019 on September 18, 2019. Reported hazard: Failed Impurities/Degradation Specifications:OOS for unknown impurity.

What should I do if I have this product?

Voluntary: Firm initiated · Letter